(Q40393792)

20 September 2017

Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species (English)

1 reference

20 September 2017

8

1 reference

20 September 2017

Vitor Hugo Moreau

3

0 references

Débora Foguel

object named as

Debora Foguel

9

0 references

Ana Paula Valente

object named as

Ana Paula Valente

6

0 references

Fabio C. L. Almeida

7

object named as

Fabio C L Almeida

1 reference

20 September 2017

Astria D Ferrão-Gonzales

1

1 reference

20 September 2017

Bruno K Robbs

2

1 reference

20 September 2017

Aricéle Ferreira

4

1 reference

20 September 2017

Luiz Juliano

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

22 July 2005

1 reference

Journal of Biological Chemistry

20 September 2017

1 reference

20 September 2017

280

1 reference

20 September 2017

41

1 reference

20 September 2017

34747-34754

1 reference

The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Experimental investigation of protein folding and misfolding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Protein aggregation and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

In silico study of amyloid beta-protein folding and oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Molecular basis for amyloid fibril formation and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Abeta-generating enzymes: recent advances in beta- and gamma-secretase research

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

The C-terminus of the beta protein is critical in amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Alzheimer's amyloid fibrils: structure and assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

A molecular model of Alzheimer amyloid beta-peptide fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

An atomic model for the pleated beta-sheet structure of abeta amyloid protofilaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

NMR View: A computer program for the visualization and analysis of NMR data

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Solution structure of residues 1-28 of the amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Involvement of electrostatic interactions in the mechanism of peptide folding induced by sodium dodecyl sulfate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Bis-ANS as a specific inhibitor for microtubule-associated protein induced assembly of tubulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Inhibition of viral capsid assembly by 1,1'-bi(4-anilinonaphthalene-5-sulfonic acid).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501651200

21 January 2018

Identifiers

DOI

10.1074/JBC.M501651200

1 reference

release_7v6lkzl2vvalnkvpvops2kx2y4

20 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7v6lkzl2vvalnkvpvops2kx2y4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference